Ticker Details
OmniAb, Inc.
IPO Date:	September 30, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$244.72M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.09 | 2.65%
Avg Daily Range (30 D):	$0.04 | 1.96%
Avg Daily Range (90 D):	$0.05 | 2.59%

Institutional Daily Volume
Avg Daily Volume:	.55M
Avg Daily Volume (30 D):	.32M
Avg Daily Volume (90 D):	.4M

Trade Size
Avg Trade Size (Sh.):	119
Avg Trade Size (Sh.) (30 D):	127
Avg Trade Size (Sh.) (90 D):	136

Institutional Trades
Total Institutional Trades:	112
Avg Institutional Trade:	$1.56M
Avg Institutional Trade (30 D):	$4.11M
Avg Institutional Trade (90 D):	$4.06M
Avg Institutional Trade Volume:	.53M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.62M
Avg Closing Trade (30 D):	$4.11M
Avg Closing Trade (90 D):	$4.11M
Avg Closing Volume:	472.37K

News

Jun 30, 2025 @ 1:50 PM AI Is Quietly Reinventing Healthcare--And Real Dep... Source: Prnewswire

May 5, 2025 @ 4:59 PM VERAXA Biotech Enters Co-discovery Alliance with O... Source: N/A

Apr 30, 2024 @ 9:55 PM USANA Health Sciences (USNA) Q1 Earnings and Reven... Source: Zacks Equity Research

Mar 26, 2024 @ 12:40 PM Over $1M Bet On OmniAb? Check Out These 3 Stocks I... Source: Avi Kapoor

Mar 5, 2024 @ 10:35 PM Plus Therapeutics (PSTV) Reports Q4 Loss, Tops Rev... Source: Zacks Equity Research

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.14	$-.15	$-.17
Diluted EPS	$-.14	$-.15	$-.17
Revenue	$2.24M	$3.9M	$4.15M
Gross Profit
Net Income / Loss	$-16.53M	$-15.88M	$-18.2M
Operating Income / Loss	$-18.14M	$-16.22M	$-18.84M
Cost of Revenue
Net Cash Flow	$10.26M	$7.39M	$-16.71M
PE Ratio